| Jul 23 |
Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
|
| Jul 22 |
Emergent BioSolutions Announces Shelf-Life Extension for NARCAN® Nasal Spray in Canada
|
| Jul 21 |
Wall Street Breakfast: The Week Ahead
|
| Jul 18 |
How To Earn $500 A Month From American Express Stock Ahead Of Q2 Earnings
|
| Jul 16 |
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
|
| Jul 15 |
Emergent BioSolutions: A Much-Needed Mid-Stage Turnaround In Process
|
| Jul 9 |
Emergent BioSolutions And Johnson & Johnson Resolve Claims Over COVID-19 Vaccine Manufacturing
|
| Jul 9 |
Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan
|
| Jul 9 |
Emergent, J&J resolve dispute over COVID vaccine manufacturing deal
|
| Jul 3 |
Emergent scores US medical countermeasure contracts worth over $250m
|
